Press release – 11.04.2018

Theraclion accelerates its sales and clinical development in Asia

• 160 treatments performed in 2017 at the Queen Mary Hospital, University of Hong Kong
• sale of another Echopulse system in the Asia region
• approval by the Taiwan health authorities of Echopulse in the treatment of breast fibroadenoma
• recent creation of a joint venture with the Chinese company Furui Medical, shipment of the first 5 systems in 2017 and official opening of the Shenzhen Theraclion office

Read the press release